
Admedus appoints two board directors
pharmafile | October 20, 2014 | Appointment | Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | John Seaberg, Wayne Paterson, admedus
Australian-based healthcare product development firm Admedus has appointed two new directors to its board.
John Seaberg and Wayne Paterson (pictured) have been appointed as independent, non-executive directors.
Seaberg takes 37 years’ experience in the medical devices industry to the firm along with a strong background in development, sales and marketing. He has been involved in both national and multi-national medical device companies, particularly in the cardiovascular space.
Paterson joins Admedus after 20 years as a senior executive in the pharma industry, with extensive managerial and marketing experience to the emerging, European and US markets. From 2007 to 2013 Paterson held senior positions at Merck Serono.
“We welcome John Seaberg and Wayne Paterson to the board and look forward to their insight and experience as Admedus continues to grow,” says Christopher Catlow, chairman of Admedus.






